In particular, the panel included extracellular and intracellular antigens expressed on normal brain and tumor cells (e.g. GFAP, CD140α, CD90), stem cells and glioma cancer stem cells (e.g. Nestin, Musashi-1, CD34). This evidence concerns the gene PDGFRA and central nervous system cancer.